Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Cardiol. Jan 26, 2012; 4(1): 15-19
Published online Jan 26, 2012. doi: 10.4330/wjc.v4.i1.15
Table 1 Baseline characteristics (mean ± SD) n (%)
HR< 70 (n = 480)HR70 (n = 561)P
Mean age65.8 ± 11.967.3 ± 11.40.035
Women128.0 (41.7)179.0 (58.3)0.037
Abdominal circumference (cm)99.5 (11.9)100.3 (13.0)NS
Body mass index28.1 (3.9)28.1 (4.0)NS
Hypertension372.0 (77.5)470.0 (83.8)0.011
Diabetes mellitus136.0 (28.3)236.0 (42.1)< 0.001
Dislipidemia416.0 (86.7)471.0 (84.0)NS
Smokers144.0 (30.3)154.0 (27.5)NS
History of heart disease208.0 (43.3)234.0 (41.7)NS
History of CVA37.0 (7.7)57.0 (10.2)NS
Peripheral Artery Disease62.0 (12.9)108.0 (19.3)0.004
Previous heart failure22.0 (4.6)61.0 (10.9)< 0.001
EF < 40%32.0 (7.5)83.0 (17.0)< 0.001
Mean SBP (mmHg)124.3 (18.5)129.6 (22.4)< 0.001
Mean DBP (mmHg)71.8 (11.2)74.2 (13.4)NS
Mean HR (bpm)60.3 (5.9)80.6 (12.6)< 0.001
Glucose (mg/dL)116.7 (46.5)131.4 (55.0)< 0.001
Hemoglobin (g/L)13.6 (1.6)13.2 (1.9)0.002
Total cholesterol (mg/dL)180.6 (40.3)180.9 (42.8)0.015
LDL cholesterol (mg/dL)109.9 (34.1)109.5 (34.6)NS
Creatinine (mg/dL)1.03 ± 0.311.13 ± 0.82NS
GFR (mL/min every 1.73 m2)77.70 ± 23.8075.30 ± 26.10NS
ASA409.0 (87.6)446.0 (86.1)NS
Diuretics81.0 (16.9)137.0 (62.8)0.003
β-blockers387.0 (80.6)379.0 (67.6)< 0.001
Calcium antagonists72.0 (15.0)119.0 (21.2)0.010
ACE inhibitors255.0 (53.1)304.0 (54.2)NS
Angiotensin II receptor blockers51.0 (10.6)80.0 (14.3)NS
Statins413.0 (86.0)453.0 (80.7)0.025
Coronary revascularization (PCI/thrombolysis)294.0 (61.2)287.0 (53.9)0.001